July 28, 2022 A Form 10-Q has been filed with the United States Securities and Exchange Commission. View SEC Filings →

You are subscribed to Alnylam Pharmaceuticals, Inc. Investor Relations' email alerts. To unsubscribe from all alerts, please click here. Alnylam Pharmaceuticals, Inc. 300 Third Street , Cambridge, MA 02142, USA Service provided by Notified